Lineage Cell Therapeutics (LCTX) FCF Margin (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported FCF Margin of -687.75% for Q2 2026, down 486.91 percentage points from -200.83% a year earlier and down 216.27 percentage points from the prior quarter.
Lineage Cell Therapeutics (LCTX) FCF Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lineage Cell Therapeutics' FCF Margin came in at -186.43%, up 25.65 percentage points year-over-year; for FY2025, it came in at -133.56%, up 115.49 percentage points from FY2024.
- FCF Margin has a five-year change of +951.71 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at -249.05% in FY2024 (+77.84 pp), -326.89% in FY2023 (-331.28 pp), 4.39% in FY2022 (+554.98 pp) and -550.59% in FY2021 (+534.68 pp).
- The Q2 2026 figure ranks as the lowest quarterly FCF Margin since Q2 2021.
- Year over year, FCF Margin gained in six of the last eight quarters, with an average year-over-year change of +18.08 percentage points.
- The high point for year-over-year FCF Margin in five years was Q1 2022 (a gain of 2318.91 percentage points); the low point was Q1 2023 (a drop of 896.42 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -471.48% (Q1 2026), -79.86% (Q4 2025) and -98.56% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | -687.75% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -687.75% |
| Mar 31, 2026 | -471.48% |
| Dec 31, 2025 | -79.86% |
| Sep 30, 2025 | -98.56% |
| Jun 30, 2025 | -200.83% |
| Mar 31, 2025 | -331.76% |
| Dec 31, 2024 | -234.00% |
| Sep 30, 2024 | -156.10% |
| Jun 30, 2024 | -371.16% |
| Mar 31, 2024 | -403.12% |
| Dec 31, 2023 | -292.62% |
| Sep 30, 2023 | -415.41% |
| Jun 30, 2023 | -202.29% |
| Mar 31, 2023 | -479.04% |
| Dec 31, 2022 | -432.74% |
| Sep 30, 2022 | -192.33% |
| Jun 30, 2022 | -157.24% |
| Mar 31, 2022 | 417.38% |
| Dec 31, 2021 | -515.33% |
| Sep 30, 2021 | -215.95% |
Lineage Cell Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();